Q15596 (NCOA2_HUMAN) Homo sapiens (Human)
Nuclear receptor coactivator 2 UniProtKBInterProSTRINGInteractive Modelling
Available Structures
348 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Crystal structure of RARalpha ligand binding domain in complex with a fragment of the TIF2 coactiva… |
Heteromer P10276; | 2×EQN; 2×GOL; | ||||
| Assess | ||||||
| Crystal structure of a dimer complex of the human glucocorticoid receptor ligand-binding domain bou… |
Heteromer P04150; | 3×BOG; 2×DEX; | ||||
| Assess | ||||||
| Crystal structure of RXRalpha ligand binding domain in complex with a fragment of the TIF2 coactiva… |
Heteromer P19793; | 2×LG2; | ||||
| Assess | ||||||
| Crystal Structure of the Androgen Receptor Ligand Binding Domain with DHT and a peptide derived fro… |
Heteromer P10275; | 1×DHT; | ||||
| Assess | ||||||
| crystal structure of human LRH-1 bound with TIF-2 peptide and phosphatidylglycerol |
Heteromer O00482; | 1×P6L; | ||||
| Assess | ||||||
| Nuclear receptor DAF-12 from hookworm Ancylostoma ceylanicum in complex with (25S)-cholestenoic acid |
Heteromer H0USY8; | 1×XCA; 6×EDO; | ||||
| Assess | ||||||
| ER-PRS*(+) (Y537S) in complex with estradiol and SRC-2 coactivator peptide |
Heteromer P03372; | 2×EST; 14×EDO; 5×GOL; 1×NA; 1×CL; | ||||
| Assess | ||||||
| Nuclear receptor DAF-12 from hookworm Ancylostoma ceylanicum in complex with (25S)-delta7-dafachron… |
Heteromer H0USY8; | 1×D7S; | ||||
| Assess | ||||||
| Crystal structure of RXR beta LBD in complexes with palmitic acid and GRIP-1 peptide |
Heteromer P28702; | 2×PLM; 2×CL; 10×EDO; | ||||
| Assess | ||||||
| Crystal structure of orphan nuclear receptor RORgamma in complex with natural ligand |
Heteromer P51449; | 1×HC3; | ||||
| Assess | ||||||
| GR in complex with desisobutyrylciclesonide |
Heteromer P04150; | 3×CPS; 1×EDO; 1×CV7; | ||||
| Assess | ||||||
| ROR gamma in complex with SCR2 and compound 3 |
Heteromer P51449; | 2×WB7; 1×GOL; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the AC-ring estroge… |
Heteromer P03372; | 2×7G0; | ||||
| Assess | ||||||
| The Wild Type Androgen Receptor Ligand Binding Domain Bound with Testosterone and a TIF2 box 3 Coac… |
Heteromer P10275; | 1×SO4; 1×TES; 1×GOL; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4… |
Heteromer P03372; | 2×5KF; | ||||
| Assess | ||||||
| Crystal structure of Retinoic Acid Receptor alpha (RXRA) in complexed with JP147 |
Heteromer P19793; | 1×7QJ; | ||||
| Assess | ||||||
| The Androgen Receptor Prostate Cancer Mutant H874Y Ligand Binding Domain Bound with Testosterone an… |
Heteromer P10275; | 1×TES; 1×GOL; | ||||
| Assess | ||||||
| HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH DIETHYLSTILBESTROL AND A GLUCOC… |
Heteromer P03372; | 1×CL; 2×DES; 2×ACY; | ||||
| Assess | ||||||
| Crystal structure of RXR gamma LBD in complexes with palmitic acid and GRIP-1 peptide |
Heteromer P48443; | 2×PLM; | ||||
| Assess | ||||||
| Glucocorticoid Receptor in complex with budesonide |
Heteromer P04150; | 1×CPS; 1×EDO; 1×GOL; 1×8W5; | ||||
| Assess | ||||||
| Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutant in Complex with Ethoxytriphenylethylene … |
Heteromer P03372; | 2×Q97; | ||||
| Assess | ||||||
| Glucocorticoid Receptor in complex with compound 31 |
Heteromer P04150; | 1×EDO; 1×B9T; | ||||
| Assess | ||||||
| Glucocorticoid Receptor in complex with AZD9567 |
Heteromer P04150; | 1×EDO; 1×B9W; | ||||
| Assess | ||||||
| Structure guided design and discovery of Indazole ethers as highly potent, non-steroidal Glucocorti… |
Heteromer P04150; | 1×EDO; 1×R8C; | ||||
| Assess | ||||||
| Glucocorticoid Receptor in complex with AZD5423 |
Heteromer P04150; | 3×EDO; 1×8W8; | ||||
| Assess | ||||||
| The discovery of potent selective glucocorticoid receptor modulators, suitable for inhalation |
Heteromer P04150; | 1×EDO; 1×NN7; | ||||
| Assess | ||||||
| Crystal structure of Retinoic Acid Receptor alpha (RXRA) in complexed with S99 inhibitor |
Heteromer P19793; | 2×T2K; | ||||
| Assess | ||||||
| Discovery of New Selective Glucocorticoid Receptor Agonist Leads |
Heteromer P04150; | 1×CPS; 1×EDO; 1×E7T; | ||||
| Assess | ||||||
| Glucocorticoid Receptor in complex with compound 4 |
Heteromer P04150; | 1×EDO; 1×B9Q; | ||||
| Assess | ||||||
| GR in complex with dexamethasone |
Heteromer P04150; | 1×CPS; 1×DEX; | ||||
| Assess | ||||||
| Crystal structure of the Retinoic Acid Receptor alpha in complex with compound 24 (JP175) |
Heteromer P19793; | 2×LFZ; | ||||
| Assess | ||||||
| FXR with DM175 and NCoA-2 peptide |
Heteromer Q96RI1; | 1×31D; 4×EDO; | ||||
| Assess | ||||||
| Crystal structure of RXR alpha LBD in complexes with palmitic acid and GRIP-1 peptide |
Heteromer P19793; | 8×EDO; 2×PLM; 2×CL; | ||||
| Assess | ||||||
| Ligand complex of RORg LBD |
Heteromer P51449; | 1×VYI; 1×DMS; | ||||
| Assess | ||||||
| Ligand complex of RORg LBD |
Heteromer P51449; | 1×JUH; 1×NA; 1×DMS; | ||||
| Assess | ||||||
| AncAR1-Rev - progesterone - Tif2 |
Heteromer | 1×STR; 3×GOL; | ||||
| Assess | ||||||
| Crystal structure of a mutated form of RXRalpha ligand binding domain in complex with LG100268 and … |
Heteromer P28700; | 2×LG2; | ||||
| Assess | ||||||
| Ligand complex of RORg LBD |
Heteromer P51449; | 1×VCH; 2×DMS; 1×NA; | ||||
| Assess | ||||||
| LRH-1 bound to SS-RJW100 and a fragment of the Tif2 Coactivator |
Heteromer O00482; | 1×QU7; | ||||
| Assess | ||||||
| Human LRH1 LBD bound to GR470 |
Heteromer O00482; | 1×470; 1×EDO; | ||||
| Assess | ||||||
| Ligand complex of RORg LBD |
Heteromer P51449; | 1×JUN; 1×DMS; 1×NA; | ||||
| Assess | ||||||
| Ligand complex of RORg LBD |
Heteromer P51449; | 1×BWE; 1×NA; | ||||
| Assess | ||||||
| Ligand complex of RORg LBD |
Heteromer P51449; | 1×I6G; 1×SWX; 1×YTZ; 1×NA; 1×DMS; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in complex with Oxabicyclic Heptene… |
Heteromer P03372; | 2×OBH; | ||||
| Assess | ||||||
| Crystal structure of RXRalpha LBD in complex with LG 100754 and a coactivator peptide |
Heteromer P19793; | 2×754; 2×ACT; | ||||
| Assess | ||||||
| Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with an A-CD ring… |
Heteromer P03372; | 2×ESE; | ||||
| Assess | ||||||
| Crystal structure of the ER alpha ligand binding domain with the agonist ortho-trifluoromethylpheny… |
Heteromer P03372; | 2×EZT; | ||||
| Assess | ||||||
| Crystal Structure of mometasone furoate-bound glucocorticoid receptor ligand binding domain |
Heteromer P04150; | 1×MOF; | ||||
| Assess | ||||||
| Ligand complex of RORg LBD |
Heteromer P51449; | 1×VCK; 1×NA; 1×DMS; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative d… |
Heteromer P03372; | 2×5K8; | ||||
| Assess | ||||||
| Crystal structure of Retinoic Acid Receptor alpha (RXRA) in complexed with S169 inhibitor |
Heteromer P19793; | 2×T72; | ||||
| Assess | ||||||
| The Crystal Structure of Human Steroidogenic Factor-1 |
Heteromer Q13285; | 1×PEF; | ||||
| Assess | ||||||
| Ligand binding to FARNESOID-X-RECEPTOR |
Heteromer Q96RI1; | 1×9MV; | ||||
| Assess | ||||||
| Ligand complex of RORg LBD |
Heteromer P51449; | 1×JUE; 1×NA; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with Coumestrol |
Heteromer P03372; | 2×CUE; | ||||
| Assess | ||||||
| Ligand complex of RORg LBD |
Heteromer P51449; | 1×8YB; 1×NA; | ||||
| Assess | ||||||
| X-ray crystal structure of a Potent Liver X Receptor Modulator |
Heteromer P55055; | 1×G58; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with 4,4'-(thiophene-2,3… |
Heteromer P03372; | 2×7ES; | ||||
| Assess | ||||||
| Crystal structure of orphan nuclear receptor RORgamma in complex with natural ligand |
Heteromer P51449; | 1×HC2; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a 4-fluorophenylamino-subst… |
Heteromer P03372; | 2×5DG; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with 4,4'-(cycloheptylid… |
Heteromer P03372; | 2×7FL; | ||||
| Assess | ||||||
| Ligand complex of RORg LBD |
Heteromer P51449; | 1×8Y8; 1×NA; 1×DMS; | ||||
| Assess | ||||||
| Crystal Structure of cortisol-bound glucocorticoid receptor ligand binding domain |
Heteromer P04150; | 1×HCY; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the estradiol deriv… |
Heteromer P03372; | 2×7FS; | ||||
| Assess | ||||||
| Ligand complex of RORg LBD |
Heteromer P51449; | 1×5IM; | ||||
| Assess | ||||||
| Human SF-1 LBD bound to synthetic agonist 6N-10CA and bacterial phospholipid |
Heteromer Q13285; | 1×IUW; 1×PEF; | ||||
| Assess | ||||||
| Structural basis for a pentacyclic oleanane-type triterpenoid as a ligand of FXR |
Heteromer Q96RI1; | 1×7VX; 3×BU3; | ||||
| Assess | ||||||
| Crystal structure of liganded hRXR-alpha/hLXR-beta heterodimer on DNA |
Heteromer P19793; P55055; | 1×9CR; 4×ZN; 1×965; | ||||
| Assess | ||||||
| ER-PRS*(+) (Y537S) in complex with genistein and SRC-2 coactivator peptide |
Heteromer P03372; | 2×GEN; 3×NA; 16×EDO; 3×CL; 1×GOL; | ||||
| Assess | ||||||
| Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutant in Complex with Stapled Peptide SRC2-P4 … |
Heteromer P03372; | 2×EST; | ||||
| Assess | ||||||
| A novel agonist of THRb |
Heteromer P10828; | 1×8HO; | ||||
| Assess | ||||||
| Human Nuclear Receptor Liver Receptor Homologue-1, LRH-1, in its apo State Bound to a Fragment of H… |
Heteromer O00482; | 1×CPS; | ||||
| Assess | ||||||
| RXR LBD in complex with 9-cis-13,14-dihydroretinoic acid |
Heteromer P19793; | 2×4XW; | ||||
| Assess | ||||||
| Human Liver Receptor Homologue-1 (LRH-1) Bound to RJW100 and a Fragment of TIF-2 |
Heteromer O00482; | 1×RJW; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the ACD-ring estrog… |
Heteromer P03372; | 2×7FZ; | ||||
| Assess | ||||||
| Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutant in Complex with Stapled Peptide SRC2-P5 |
Heteromer P03372; | 2×EST; 2×GOL; | ||||
| Assess | ||||||
| Crystal structure of the human RXR alpha ligand binding domain bound to the synthetic agonist compo… |
Heteromer P19793; | 2×BM6; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE at 1.9 ANGSTROEMS RESOLUTION OF THE HOMODIMER OF HUMAN RXR ALPHA LIGAND BINDING D… |
Heteromer P19793; | 2×BM6; | ||||
| Assess | ||||||
| Crystal Structure of the human RXR alpha ligand binding domain bound to the eicosanoid DHA (Docosa … |
Heteromer P19793; | 2×HXA; | ||||
| Assess | ||||||
| Crystal structure of human Retinoid X receptor alpha ligand binding domain complex with 9cUAB110 an… |
Heteromer P19793; | 2×3SW; | ||||
| Assess | ||||||
| Human Liver Receptor Homologue-1 (LRH-1) Bound to a RJW100 stereoisomer and a Fragment of TIF-2 |
Heteromer O00482; | 1×71W; | ||||
| Assess | ||||||
| Stapled peptide bound to Estrogen Receptor Beta |
Heteromer Q92731; | 2×YJD; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in complex with Diethylstilbestrol |
Heteromer P03372; | 2×DES; | ||||
| Assess | ||||||
| A novel chemical derivative(56) of THRB agonist |
Heteromer P10828; | 1×9II; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the OBHS-ASC compou… |
Heteromer P03372; | 2×7K6; | ||||
| Assess | ||||||
| Estrogen-related receptor beta(ERR2) in complex with BPA |
Heteromer O95718; | 2×2OH; | ||||
| Assess | ||||||
| Crystal structure of human Retinoid X Receptor alpha-ligand binding domain complex with 5-methyl UA… |
Heteromer P19793; | 2×2W0; | ||||
| Assess | ||||||
| Crystal structure of human Retinoid X Receptor alpha-ligand binding domain complex with 9cUAB30 and… |
Heteromer P19793; | 2×1O8; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4… |
Heteromer P03372; | 2×5KE; | ||||
| Assess | ||||||
| Crystal structure of the Retinoid X Receptor alpha in complex with synthetic honokiol derivative 7 … |
Heteromer P19793; | 2×I5W; 2×CL; | ||||
| Assess | ||||||
| Crystal structure of human Retinoid X Receptor alpha-ligand binding domain complex with 7-methyl UA… |
Heteromer P19793; | 2×2VP; | ||||
| Assess | ||||||
| Crystal structure of human Retinoid X Receptor alpha-ligand binding domain complex with 6-methyl UA… |
Heteromer P19793; | 2×2VZ; | ||||
| Assess | ||||||
| Human Nuclear Receptor Liver Receptor Homologue-1, LRH-1, Bound to DLPC and a Fragment of TIF-2 |
Heteromer O00482; | 3×1PE; 1×PLC; | ||||
| Assess | ||||||
| Human Liver Receptor Homolog-1 bound to the agonist 5N and a fragment of the Tif2 coregulator |
Heteromer O00482; | 1×N1V; | ||||
| Assess | ||||||
| Crystal structure of human estrogen receptor alpha LBD in complex with GRIP peptide and estriol |
Heteromer P03372; | 1×ESL; 4×CL; | ||||
| Assess | ||||||
| Crystal structure of human Retinoid X Receptor alpha-ligand binding domain complex with 9-cis retin… |
Heteromer P19793; | 2×9CR; | ||||
| Assess | ||||||
| Crystal structure of VDR-LBD complexed with 22S-butyl-25-hydroxyphenyl-2-methylidene-19,26,27-trino… |
Heteromer P13053; | 1×8C9; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with 4,4'-((1,3-dihydro-… |
Heteromer P03372; | 2×7FJ; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the estradiol deriv… |
Heteromer P03372; | 2×7FR; | ||||
| Assess | ||||||
| Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutant in Complex with Stapled Peptide SRC2-P1 … |
Heteromer P03372; | 2×EST; 2×GOL; 1×CL; | ||||
| Assess | ||||||
| Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutant in Complex with Stapled Peptide SRC2-P3 … |
Heteromer P03372; | 2×EST; 1×CL; | ||||
| Assess | ||||||
| Glucocorticoid Receptor with Bound alaninamide 10 with TIF2 peptide |
Heteromer P04150; | 1×JZS; 1×JZR; | ||||
| Assess | ||||||
| Crystal structure of human retinoic X receptor alpha complexed with bigelovin and coactivator SRC-1 |
Heteromer P19793; | 2×BGV; | ||||
| Assess | ||||||
| Crystal structure of human retinoid X receptor alpha-ligand binding domain complex with Targretin a… |
Heteromer P19793; | 2×9RA; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with 3,4-bis(4-hydroxyph… |
Heteromer P03372; | 2×7EH; 4×7G5; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4… |
Heteromer P03372; | 2×5KG; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4… |
Heteromer P03372; | 2×5JX; | ||||
| Assess | ||||||
| Glucocorticoid Receptor LBD bound to GSK866 |
Heteromer P04150; | 2×866; 3×GOL; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the Arene Core OBHS… |
Heteromer P03372; | 2×7M1; | ||||
| Assess | ||||||
| Human LRH-1 bound to the agonist 2N and a fragment of the Tif2 coregulator |
Heteromer O00482; | 1×N27; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with 2,3-bis(2-chloro-4-… |
Heteromer P03372; | 2×7EN; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF HUMAN RETINOID X RECEPTOR ALPHA-LIGAND BINDING DOMAIN COMPLEX WITH (R)4-METHYL… |
Heteromer P19793; | 2×R4M; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the Constrained WAY… |
Heteromer P03372; | 2×7EF; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the estradiol deriv… |
Heteromer P03372; | 2×7FQ; | ||||
| Assess | ||||||
| Human LRH-1 bound to the agonist 6N and a fragment of the Tif2 coregulator |
Heteromer O00482; | 1×N2J; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4… |
Heteromer P03372; | 2×5K0; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the Cyclofenil-ASC … |
Heteromer P03372; | 2×7FG; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the OBHS-ASC compou… |
Heteromer P03372; | 2×7E1; | ||||
| Assess | ||||||
| Human LRH-1 ligand-binding domain bound to agonist cpd 15 and fragment of coregulator TIF-2 |
Heteromer O00482; | 1×QY4; | ||||
| Assess | ||||||
| Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutant in Complex with Stapled Peptide SRC2-SP2… |
Heteromer P03372; | 2×EST; 2×GOL; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the Cyclofenil-ASC … |
Heteromer P03372; | 2×7FD; | ||||
| Assess | ||||||
| Retinoic acid receptor alpha in complex with chiral dihydrobenzofuran benzoic acid 9a and a fragmen… |
Heteromer P19793; | 2×5LO; | ||||
| Assess | ||||||
| Estrogen Receptor Alpha Ligand Binding Domain in Complex with Estradiol and SRC2-BCP1 |
Heteromer P03372; | 2×EST; | ||||
| Assess | ||||||
| Crystal structure of human Retinoid X Receptor alpha-ligand binding domain complex with 8-methyl UA… |
Heteromer P19793; | 2×2VR; | ||||
| Assess | ||||||
| Crystal structure of human Retinoid X receptor alpha ligand binding domain complex with 9cUAB111 an… |
Heteromer P19793; | 2×3T2; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with Oxabicyclic Heptene… |
Heteromer P03372; | 2×OB1; | ||||
| Assess | ||||||
| A novel chemical derivative(53) of THRB agonist |
Heteromer P10828; | 1×9GC; | ||||
| Assess | ||||||
| Crystal structure of dimeric RXR-LBD complexed with full agonist NEt-3IB and TIF2 co-activator |
Heteromer P19793; | 2×E80; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the OBHS-ASC compou… |
Heteromer P03372; | 2×7JY; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4… |
Heteromer P03372; | 2×5HZ; | ||||
| Assess | ||||||
| A moderator XD22 binding to bile acid receptor |
Heteromer Q96RI1; | 1×XD5; | ||||
| Assess | ||||||
| Crystal structure of human retinoid X Receptor alpha-ligand binding domain complex with 9cUAB70 and… |
Heteromer P19793; | 2×3RB; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF HUMAN RETINOID X RECEPTOR ALPHA-LIGAND BINDING DOMAIN COMPLEX WITH (S) 4-Methy… |
Heteromer P19793; | 2×29V; | ||||
| Assess | ||||||
| X-ray Crystal Structure of AncGR2 in Complex with Dexamethasone |
Heteromer | 1×DEX; | ||||
| Assess | ||||||
| The Crystal Structure of Human Liver Receptor Homologue-1 |
Heteromer O00482; | 1×P3A; 1×TRS; | ||||
| Assess | ||||||
| X-Ray Crystal Structure of the Ancestral Glucocorticoid Receptor 2 ligand binding domain in complex… |
Heteromer | 1×GOL; 1×MOF; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the OBHS-ASC compou… |
Heteromer P03372; | 2×7J9; | ||||
| Assess | ||||||
| A novel chemical derivative(92) of THRB agonist |
Heteromer P10828; | 1×9IW; | ||||
| Assess | ||||||
| A novel chemical derivative(89) of THRB agonist |
Heteromer P10828; | 1×9IT; | ||||
| Assess | ||||||
| THRb mutation with a novel agonist |
Heteromer P10828; | 1×8HO; | ||||
| Assess | ||||||
| LRH-1 bound to small molecule Tet and fragment of coactivator Tif2 |
Heteromer O00482; | 1×XKE; | ||||
| Assess | ||||||
| Structural insight of the molecular mechanism of cilofexor bound to FXR |
Heteromer Q96RI1; | 1×811; | ||||
| Assess | ||||||
| FXR ligand binding domain |
Heteromer Q96RI1; | 1×93U; | ||||
| Assess | ||||||
| A novel chemical derivative(85) of THRB agonist |
Heteromer P10828; | 1×9IQ; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the imidazopyridine… |
Heteromer P03372; | 2×5P1; | ||||
| Assess | ||||||
| Structural basis of tropifexor as a potent and selective agonist for farnesoid X receptor |
Heteromer Q96RI1; | 1×GWF; | ||||
| Assess | ||||||
| Crystal Structure of human retinoid X receptor alpha-ligand binding domain complex with 9cUAB76 and… |
Heteromer P19793; | 2×3SV; | ||||
| Assess | ||||||
| Crystal structure of a mixed agonist-bound RAR-alpha and antagonist-bound RXR-alpha heterodimer lig… |
Heteromer P10276; P28700; | 1×754; 1×REA; | ||||
| Assess | ||||||
| THRb mutation with a novel agonist |
Heteromer P10828; | 1×8HO; | ||||
| Assess | ||||||
| A novel chemical derivative(71) of THRB agonist |
Heteromer P10828; | 1×9IL; | ||||
| Assess | ||||||
| Crystal structure of the human RXR alpha ligand binding domain bound to a synthetic agonist compoun… |
Heteromer P19793; | 2×21P; | ||||
| Assess | ||||||
| A novel chemical derivative(52) of THRB agonist |
Heteromer P10828; | 1×9IF; | ||||
| Assess | ||||||
| A ligand binding to FXR |
Heteromer Q96RI1; | 1×93O; | ||||
| Assess | ||||||
| A ligand F binding to FXR |
Heteromer Q96RI1; | 1×93R; | ||||
| Assess | ||||||
| Crystal structure of the human RXR alpha ligand binding domain bound to a synthetic agonist compoun… |
Heteromer P19793; | 2×P26; | ||||
| Assess | ||||||
| Crystal structure of a mutated form of RXRalpha ligand binding domain in complex with BMS649 and a … |
Heteromer P28700; | 2×BM6; | ||||
| Assess | ||||||
| Crystal structure of dimeric RXR-LBD complexed with NEt-3ME and TIF2 co-activator |
Heteromer P19793; | 2×E8L; 8×EDO; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with an N-ethyl, 4-chlor… |
Heteromer P03372; | 1×OB7; 1×OB6; | ||||
| Assess | ||||||
| Ligand complex of RORg LBD |
Heteromer P51449; | 1×4TU; 1×NA; | ||||
| Assess | ||||||
| Ligand complex of RORg LBD |
Heteromer P51449; | 1×6VD; 1×NA; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in complex with a 2-Methoxy-substit… |
Heteromer P03372; | 2×4Q7; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with an N-trifluoroethyl… |
Heteromer P03372; | 2×OBT; | ||||
| Assess | ||||||
| Crystal structure of the ligand binding domain of the retinoid X receptor alpha in complex with 3-(… |
Heteromer P19793; | 2×3TN; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with an N-methyl Substit… |
Heteromer P03372; | 2×OB2; | ||||
| Assess | ||||||
| Ligand complex of RORg LBD |
Heteromer P51449; | 1×8Y5; 1×NA; 1×DMS; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with an N-methyl, 2-chlo… |
Heteromer P03372; | 3×OB3; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in complex with a 3-Fluoro-substitu… |
Heteromer P03372; | 2×OFB; | ||||
| Assess | ||||||
| Crystal structure of human Retinoid X receptor alpha ligand binding domain complex with UAB116 and … |
Heteromer P19793; | 1×OI2; | ||||
| Assess | ||||||
| Crystal structure of RXRalpha ligand binding domain in complex with tributyltin and a coactivator f… |
Heteromer P19793; | 2×TBY; 2×ACT; | ||||
| Assess | ||||||
| Estrogen Receptor Alpha Ligand Binding Domain Y537S in Complex with 3-(((2-chloro-5-phenylthieno[2,… |
Heteromer P03372; | 2×98L; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with octane-1,8-diyl bis… |
Heteromer P03372; | 2×7ED; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with an N-trifluoroethyl… |
Heteromer P03372; | 3×OB9; | ||||
| Assess | ||||||
| Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with a Dynamic Ox… |
Heteromer P03372; | 2×15Q; | ||||
| Assess | ||||||
| Ligand complex of RORg LBD |
Heteromer P51449; | 1×8Y2; 1×NA; | ||||
| Assess | ||||||
| Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with Dynamic WAY-… |
Heteromer P03372; | 2×1GT; | ||||
| Assess | ||||||
| Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with Constrained … |
Heteromer P03372; | 2×1GU; | ||||
| Assess | ||||||
| Crystal structure of human retinoic X receptor alpha ligand-binding domain complexed with LX0278 an… |
Heteromer P19793; | 2×LX8; | ||||
| Assess | ||||||
| Crystal Structure of the Retinoid X Receptor Ligand Binding Domain Bound to the Synthetic Agonist 3… |
Heteromer P19793; | 1×2E3; | ||||
| Assess | ||||||
| Crystal structure of human FXR in complex with a functional drug ligand |
Heteromer Q96RI1; | 1×D5H; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with a Resorcinyl 4-Fluoro-subst… |
Heteromer P03372; | 2×5J2; | ||||
| Assess | ||||||
| Crystal structure of the orphan nuclear receptor ROR(gamma)t ligand-binding domain in complex with … |
Heteromer P51449; | 1×NBH; 1×DMX; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with an N-ethyl, alpha-n… |
Heteromer P03372; | 2×OB8; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4… |
Heteromer P03372; | 2×5K4; | ||||
| Assess | ||||||
| Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with Dynamic WAY-… |
Heteromer P03372; | 2×KN3; | ||||
| Assess | ||||||
| Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with Constrained … |
Heteromer P03372; | 1×1GJ; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a dichloro-substituted, 3-m… |
Heteromer P03372; | 2×5EU; | ||||
| Assess | ||||||
| Ligand complex of RORg LBD |
Heteromer P51449; | 1×A7W; 1×NA; 1×DMS; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with an N-ethyl, 4-metho… |
Heteromer P03372; | 1×OB5; 1×OB4; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the OBHS-BSC Analog… |
Heteromer P03372; | 1×7EH; 1×7ET; | ||||
| Assess | ||||||
| Ligand complex of RORg LBD |
Heteromer P51449; | 1×76E; 1×NA; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with a para-Hydroxyl-substituted… |
Heteromer P03372; | 2×5FY; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the Spiro BC-estrad… |
Heteromer P03372; | 2×7G1; | ||||
| Assess | ||||||
| Human Estrogen Receptor Alpha Ligand-Binding Domain In Complex With OBCP-2M and A Glucocorticoid Re… |
Heteromer P03372; | 2×459; | ||||
| Assess | ||||||
| Crystal structure of human Retinoid X receptor alpha ligand binding domain complex with UAB113 and … |
Heteromer P19793; | 1×OI5; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a phenylamino-substituted, … |
Heteromer P03372; | 2×5C4; | ||||
| Assess | ||||||
| Human estrogen receptor alpha ligand-binding domain and a glucocorticoid receptor-interacting prote… |
Heteromer P03372; | |||||
| Assess | ||||||
| Crystal structure of Glucocorticoid Receptor in complex with an inhibitor |
Heteromer P04150; | 2×A1ACE; | ||||
| Assess | ||||||
| Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with Dynamic WAY-… |
Heteromer P03372; | 2×1GR; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with 3,4-bis(2-fluoro-4-… |
Heteromer P03372; | 2×7ER; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a t-butyl-substituted, meth… |
Heteromer P03372; | 2×5C7; | ||||
| Assess | ||||||
| Crystal structure of the Retinoic Acid Receptor alpha in complex with a synthetic spiroketal agonis… |
Heteromer P19793; | 2×7BE; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the Dynamic WAY der… |
Heteromer P03372; | 2×6WL; | ||||
| Assess | ||||||
| Crystal structure of the ligand binding domain of the retinoid X receptor alpha in complex with 3-(… |
Heteromer P19793; | 2×4TN; | ||||
| Assess | ||||||
| Crystal structure of the ligand binding domain of the retinoid X receptor alpha in complex with 3-(… |
Heteromer P19793; | 2×5TN; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4… |
Heteromer P03372; | 2×5JY; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4… |
Heteromer P03372; | 2×5HX; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in complex with Oxabicyclic Heptene… |
Heteromer P03372; | 2×OBH; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4… |
Heteromer P03372; | 2×5KB; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the PEG-linked Dime… |
Heteromer P03372; | 2×7EE; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4… |
Heteromer P03372; | 2×5J1; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the OBHS-ASC compou… |
Heteromer P03372; | 2×7EV; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative m… |
Heteromer P03372; | 2×5K7; | ||||
| Assess | ||||||
| Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with a Dynamic Th… |
Heteromer P03372; | 2×1GV; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the Arene Core OBHS… |
Heteromer P03372; | 2×7M7; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with a Sulfoxide-bridged Oxabicy… |
Heteromer P03372; | 2×5FT; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a difluoro-substituted A-CD… |
Heteromer P03372; | 2×5CK; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the A-CD ring estro… |
Heteromer P03372; | 2×6WU; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a trifluoro-substituted A-C… |
Heteromer P03372; | 2×5CJ; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a trifluoromethyl-substitut… |
Heteromer P03372; | 2×5CE; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a dichloro-substituted, 2,5… |
Heteromer P03372; | 2×5ET; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in complex with an methyl-substituted A-CD … |
Heteromer P03372; | 2×5CQ; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with 16-benzylidene estr… |
Heteromer P03372; | 2×6WN; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with 16b-benzyl 17b-estr… |
Heteromer P03372; | 2×6WM; | ||||
| Assess | ||||||
| Human Estrogen Receptor Alpha Ligand-Binding Domain In Complex With OBCP-3M and A Glucocorticoid Re… |
Heteromer P03372; | 2×689; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with a Sulfoxide-bridged Oxabicy… |
Heteromer P03372; | 2×5FV; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a triaryl-ethylene compound… |
Heteromer P03372; | 2×5DJ; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4… |
Heteromer P03372; | 2×5K2; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4… |
Heteromer P03372; | 2×5HW; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the OBHS derivative… |
Heteromer P03372; | 2×7FP; | ||||
| Assess | ||||||
| Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with Constrained … |
Heteromer P03372; | 1×1GM; | ||||
| Assess | ||||||
| Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with Constrained … |
Heteromer P03372; | 2×1GS; | ||||
| Assess | ||||||
| Human estrogen receptor alpha ligand-binding domain in complex with 2-(but-1-enyl)-17beta-estradiol… |
Heteromer P03372; | 2×DRQ; | ||||
| Assess | ||||||
| Human Liver Receptor Homolog-1 in Complex with 10CA and a Fragment of Tif2 |
Heteromer O00482; | 1×VQA; | ||||
| Assess | ||||||
| Crystal structure of RXRalpha ligand binding domain in complex with triphenyltin and a coactivator … |
Heteromer P19793; | 2×T9T; 2×ACT; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in complex with a 4-Bromo-substitut… |
Heteromer P03372; | 2×OBM; | ||||
| Assess | ||||||
| Development of synthetically accessible non-secosteroidal hybrid molecules combining vitamin D rece… |
Heteromer Q9PTN2; | 2×0U3; | ||||
| Assess | ||||||
| Crystal structure of human RXRalpha ligand binding domain in complex with 2,4-di-tert-butylphenol a… |
Heteromer P19793; | 2×UGW; 1×FMT; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the phenylamino-sub… |
Heteromer P03372; | 2×6WV; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the OBHS analog, 4-… |
Heteromer P03372; | 2×7FO; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with 4,4'-((5-bromo-2,3-… |
Heteromer P03372; | 2×6WQ; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in complex with a 2-Methyl-substitu… |
Heteromer P03372; | 2×4Q9; | ||||
| Assess | ||||||
| Development of synthetically accessible non-secosteroidal hybrid molecules combining vitamin D rece… |
Heteromer Q9PTN2; | 2×0S4; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with Zearalenone |
Heteromer P03372; | 2×ZER; | ||||
| Assess | ||||||
| Crystal structure of dimeric RXR-LBD complexed with partial agonist NEt-4IB and TIF2 co-activator |
Heteromer P19793; | 2×E8O; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a 3-methylphenylamino-subst… |
Heteromer P03372; | 3×5C9; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the A-CD ring estro… |
Heteromer P03372; | 2×6WR; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the imidazopyridine… |
Heteromer P03372; | 2×5OR; | ||||
| Assess | ||||||
| Crystal structure of orphan nuclear receptor RORgamma in complex with natural ligand |
Heteromer P51449; | 1×HC9; | ||||
| Assess | ||||||
| Structure-function study of Gemini derivatives with two different side chains at C-20, Gemini-0072 … |
Heteromer Q9PTN2; | 2×G72; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with DDT and DDE |
Heteromer P03372; | 1×6WS; 1×6WT; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a nitrile-substituted triar… |
Heteromer P03372; | 2×5DH; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with a Resorcinyl 2-Chloro-subst… |
Heteromer P03372; | 2×5G3; | ||||
| Assess | ||||||
| Diastereotopic and Deuterium Effects in Gemini |
Heteromer Q9PTN2; | 2×BIV; | ||||
| Assess | ||||||
| A unique binding model of FXR LBD with feroline |
Heteromer Q96RI1; | 1×FEZ; | ||||
| Assess | ||||||
| Structural analysis and biological activities of BXL0124, a Gemini analog of Vitamin D |
Heteromer Q9PTN2; | 2×6VH; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4… |
Heteromer P03372; | 2×5K5; | ||||
| Assess | ||||||
| Retinoic acid receptor alpha in complex with (E)-3-(3'-allyl-6-hydroxy-[1,1'-biphenyl]-3-yl)acrylic… |
Heteromer P19793; | 2×2QO; | ||||
| Assess | ||||||
| Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutant in Complex with 3OHTPE and GRIP Peptide |
Heteromer P03372; | 2×FYS; | ||||
| Assess | ||||||
| Structure-function of Gemini derivatives with two different side chains at C-20, Gemini-0072 and Ge… |
Heteromer Q9PTN2; | 2×H97; | ||||
| Assess | ||||||
| Human Liver Receptor Homolog-1 in Complex with 9ChoP and a Fragment of Tif2 |
Heteromer O00482; | 1×VQY; | ||||
| Assess | ||||||
| Novel natural FXR modulator with a unique binding mode |
Heteromer Q96RI1; | 2×T73; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a 3-naphthyl-substituted, m… |
Heteromer P03372; | 2×5C8; | ||||
| Assess | ||||||
| Interaction between vitamin D receptor and coactivator peptide SRC2-3 |
Heteromer P13053; | 1×VDX; | ||||
| Assess | ||||||
| Discovery of novel, orally efficacious Liver X Receptor (LXR) beta agonists |
Heteromer P28702; P55055; | 1×67S; | ||||
| Assess | ||||||
| THRb mutation with a novel agonist |
Heteromer P10828; | 1×8HO; | ||||
| Assess | ||||||
| Diastereotopic and Deuterium Effects in Gemini |
Heteromer Q9PTN2; | 2×BIV; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with an a-naphthyl Subst… |
Heteromer P03372; | 2×6WP; | ||||
| Assess | ||||||
| Diastereotopic and Deuterium Effects in Gemini |
Heteromer Q9PTN2; | 2×BIV; | ||||
| Assess | ||||||
| Human LRH-1 LBD bound to agonist 6N-10CA and fragment of Tif2 coactivator |
Heteromer O00482; | 1×IUW; | ||||
| Assess | ||||||
| Crystal structure of RXRalphaLBD complexed with the agonist magnolol |
Heteromer P19793; | 2×MLO; | ||||
| Assess | ||||||
| Crystal structure of zVDR L337H mutant-gemini complex |
Heteromer Q9PTN2; | 2×BIV; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex the 3,4-diaryl-furan der… |
Heteromer P03372; | 2×5OS; | ||||
| Assess | ||||||
| Multi-Domain Organization of the HNF4alpha Nuclear Receptor Complex on DNA |
Heteromer P41235; | 2×MYR; 4×ZN; | ||||
| Assess | ||||||
| Crystal structure of the LXRalfa-RXRbeta LBD heterodimer |
Heteromer P28702; Q13133; | 1×MEI; 1×444; | ||||
| Assess | ||||||
| crystal structure of VDR complex with D-Bishomo-1a,25-dihydroxyvitamin D3 Analog 57 |
Heteromer Q9PTN2; | 1×IG0; | ||||
| Assess | ||||||
| Diastereotopic and Deuterium Effects in Gemini |
Heteromer Q9PTN2; | 2×BIV; | ||||
| Assess | ||||||
| Intact PPAR gamma - RXR alpha Nuclear Receptor Complex on DNA bound with Rosiglitazone, 9-cis Retin… |
Heteromer P19793; P37231; | 1×9CR; 4×ZN; 1×BRL; | ||||
| Assess | ||||||
| Intact PPAR gamma - RXR alpha Nuclear Receptor Complex on DNA bound with GW9662, 9-cis Retinoic Aci… |
Heteromer P19793; P37231; | 4×ZN; 1×9CR; 1×GW9; | ||||
| Assess | ||||||
| Crystal structure of multi-domain RAR-beta-RXR-alpha heterodimer on DNA |
Heteromer P10826; P19793; | 4×ZN; 1×9CR; 1×REA; | ||||
| Assess | ||||||
| Human Nuclear Receptor Liver Receptor Homologue-1, LRH-1, Bound to an E. Coli Phospholipid and a Fr… |
Heteromer O00482; | 1×EPH; 3×CPS; | ||||
| Assess | ||||||
| Human estrogen receptor alpha ligand-binding domain in complex with 17methyl-17alpha-dihydroequilen… |
Heteromer P03372; | 2×17M; | ||||
| Assess | ||||||
| Human estrogen receptor alpha ligand-binding domain in complex with OBCP-1M and a glucocorticoid re… |
Heteromer P03372; | 2×458; | ||||
| Assess | ||||||
| Dual Modulators |
Heteromer P03372; | 1×WVW; 1×WVR; | ||||
| Assess | ||||||
| Vitamin D Receptor complex with lithocholic acid |
Heteromer Q9PTN2; | 4×4OA; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in complex with a 3-Bromo-substitut… |
Heteromer P03372; | 2×OBB; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with a 2-Chloro-substituted Tria… |
Heteromer P03372; | 2×5G5; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in complex with a 2-Fluoro-substitu… |
Heteromer P03372; | 3×OBC; | ||||
| Assess | ||||||
| Crystal structure of RORgamma in complex with natural inverse agonist |
Heteromer P51449; | 1×97I; | ||||
| Assess | ||||||
| Crystal structure of HNF4 alpha LBD in complexes with palmitic acid and GRIP-1 peptide |
Heteromer P41235; | 2×PLM; 3×EDO; | ||||
| Assess | ||||||
| Dual Modulators |
Heteromer P03372; | 2×LYQ; 2×WVE; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4… |
Heteromer P03372; | 2×5KD; | ||||
| Assess | ||||||
| AncAR1 - progesterone - Tif2 |
Heteromer | 1×DHT; 1×GOL; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the Methyl(phenyl)a… |
Heteromer P03372; | 2×6WW; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4… |
Heteromer P03372; | 2×5KA; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a dichloro-substituted, 3,4… |
Heteromer P03372; | 2×5G2; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the OBHS-ASC analog… |
Heteromer P03372; | 2×7M4; | ||||
| Assess | ||||||
| Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with Resveratrol |
Heteromer P03372; | 2×STL; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with (E)-4,4''-dihydroxy… |
Heteromer P03372; | 2×7EG; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with 2,5-bis(2-fluoro-4-… |
Heteromer P03372; | 2×7EQ; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with (E)-3'-fluoro-4'-hy… |
Heteromer P03372; | 3×7G2; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the OBHS-ASC Analog… |
Heteromer P03372; | 4×7E3; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a phenylamino-substituted e… |
Heteromer P03372; | 2×5CC; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with a 2-Methyl-substituted Tria… |
Heteromer P03372; | 2×5G7; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with a Squaric Acid-link… |
Heteromer P03372; | 2×7EE; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a dimethyl-substituted, 3,4… |
Heteromer P03372; | 2×5FS; | ||||
| Assess | ||||||
| Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with Dynamic WAY … |
Heteromer P03372; | 2×1GQ; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 3… |
Heteromer P03372; | 2×5J0; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a 4-fluorophenylamino-subst… |
Heteromer P03372; | 2×5ES; | ||||
| Assess | ||||||
| HUMAN OESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH 17BETA-OESTRADIOL AND TIF2 NRB… |
Heteromer P03372; | 1×EST; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with (E)-2-chloro-4'-hyd… |
Heteromer P03372; | 2×7EL; | ||||
| Assess | ||||||
| HUMAN OESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH RALOXIFENE CORE AND TIF2 NRBOX… |
Heteromer P03372; | 2×ZTW; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4… |
Heteromer P03372; | 2×5K1; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with 4,4',4''-(thiophene… |
Heteromer P03372; | 2×7EM; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the OBHS-ASC Analog… |
Heteromer P03372; | 5×7KL; | ||||
| Assess | ||||||
| Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutant in Complex with Z2OHTPE and a glucocorti… |
Heteromer P03372; | 2×FNJ; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a 2-naphthylamino-substitut… |
Heteromer P03372; | 2×5C6; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with 2,5-bis(2-chloro-4-… |
Heteromer P03372; | 2×7EO; | ||||
| Assess | ||||||
| Human Estrogen Receptor Alpha Ligand-Binding Domain In Complex With OBCP-1M-G and A Glucocorticoid … |
Heteromer P03372; | 2×T3O; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with (E)-4'-hydroxy-3-((… |
Heteromer P03372; | 2×7G3; | ||||
| Assess | ||||||
| Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with Fluoro-Resve… |
Heteromer P03372; | 2×FSV; | ||||
| Assess | ||||||
| THRb mutation with a novel agonist |
Heteromer P10828; | 1×8HO; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF THE AGONIST FORM OF GLUCOCORTICOID RECEPTOR |
Heteromer P04150; | 1×DEX; | ||||
| Assess | ||||||
| Crystal structure of VDR in complex with D-Bishomo-1a,25-dihydroxyvitamin D3 Analog 55 |
Heteromer Q9PTN2; | 1×IFK; | ||||
| Assess | ||||||
| A structure of FXR/RXR |
Heteromer P19793; Q96RI1; | 1×33Y; 1×9CR; | ||||
| Assess | ||||||
| Ligand binding domain of the glucocorticoid receptor complexed with fluticazone furoate |
Heteromer P04150; | 2×GW6; | ||||
| Assess | ||||||
| Glucocorticoid Receptor with Bound D-prolinamide 11 |
Heteromer P04150; | 1×JZN; | ||||
| Assess | ||||||
| Intact PPAR gamma - RXR alpha Nuclear Receptor Complex on DNA bound with BVT.13, 9-cis Retinoic Aci… |
Heteromer P19793; P37231; | 4×ZN; 1×9CR; 1×PLB; | ||||
| Assess | ||||||
| Crystal structure of RORgamma in complex with natural inverse agonist |
Heteromer P51449; | 1×88K; | ||||
| Assess | ||||||
| Apo Estrogen Receptor Alpha Ligand Binding Domain D538G Mutant with a glucocorticoid receptor-inter… |
Heteromer P03372; | |||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Triaryl-substituted Imi… |
Heteromer P03372; | 2×5G4; | ||||
| Assess | ||||||
| Estrogen Receptor Alpha Ligand Binding Domain Y537S in Complex with TTC-352 and GRIP Peptide |
Heteromer P03372; | 2×V9J; | ||||
| Assess | ||||||
| Estrogen Receptor Alpha Ligand Binding Domain Y537S in Complex with 2-chloro-4-((4-hydroxybenzyl)am… |
Heteromer P03372; | 1×EMY; | ||||
| Assess | ||||||
| Crystal structure of RORgamma complexed with SRC2 and compound 5d |
Heteromer P51449; | 1×4CZ; | ||||
| Assess | ||||||
| Crystal Structure of the T3-bound TR-beta Ligand-binding Domain in complex with RXR-alpha |
Heteromer P10828; P19793; | 1×T3; | ||||
| Assess | ||||||
| Estrogen Receptor Alpha Ligand Binding Domain Y537S in Complex with 4-(((2-chloro-5-phenylthieno[2,… |
Heteromer P03372; | 1×5VP; | ||||
| Assess | ||||||
| Crystal structure of the androgen receptor ligand binding domain with DHT and a peptide derived for… |
Heteromer P10275; | 1×DHT; | ||||
| Assess | ||||||
| The Estrogen Receptor Alpha Ligand Binding Domain D538G Mutant in Complex with Estradiol and a gluc… |
Heteromer P03372; | 2×EST; | ||||
| Assess | ||||||
| A ligand M binding to FXR |
Heteromer Q96RI1; | 1×NIW; | ||||
| Assess | ||||||
| Estrogen Receptor Alpha Ligand Binding Domain C381S C417S Y537S Mutant in Complex with an Covalent … |
Heteromer P03372; | 1×PEG; | ||||
| Assess | ||||||
| Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with a Triaryl-imine analog 4,4'… |
Heteromer P03372; | 2×5G6; | ||||
| Assess | ||||||
| Crystal structure of a tridecameric superhelix | homo-13-mer | 24×SO4; 13×CHD; | ||||
| Assess | ||||||
| X-ray structure of nuclear receptor ROR-gammat Ligand Binding Domain + SRC2 peptide | monomer | 1×NA; | ||||
| Assess | ||||||
| X-ray co-structure of nuclear receptor ROR-gammat Ligand Binding Domain with an inverse agonist and… | monomer | 1×NA; 1×927; | ||||
| Assess | ||||||
| X-ray co-structure of nuclear receptor ROR-gammat Ligand Binding Domain with an inverse agonist and… | monomer | 1×NA; 1×92A; | ||||
| Assess | ||||||
| X-ray co-structure of nuclear receptor ROR-gammat Ligand Binding Domain with an agonist and SRC2 pe… | monomer | 1×NA; 1×921; | ||||
| Assess | ||||||
| X-ray co-structure of nuclear receptor ROR-gammat Ligand Binding Domain with a inverse agonist and … | monomer | 1×NA; 1×9GS; | ||||
| Assess | ||||||
| X-ray co-structure of nuclear receptor ROR-gammat Ligand Binding Domain with a inverse agonist and … | monomer | 1×9GV; | ||||
| Assess | ||||||
| Solution structure of the estrogen receptor-binding stapled peptide SP1 (Ac-HXILHXLLQDS-NH2) | monomer | |||||
| Assess | ||||||